Reactive oxygen species as an independent marker of male factor infertility

Ashok Agarwal1, Rakesh K Sharma, Kiran P Nallella

  • 1Center for Advanced Research in Human Reproduction, Infertility and Sexual Function, Glickman Urological Institute and Department of Obstetrics-Gynecology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. agarwaa@ccf.org

Fertility and Sterility
|October 10, 2006
PubMed
Abstract

Insights

High reactive oxygen species (ROS) levels are an independent marker for male factor infertility (MFI), regardless of sperm parameters. Measuring ROS can aid in evaluating idiopathic infertility and guide antioxidant treatment.

Area of Science:

  • Reproductive Medicine
  • Andrology
  • Biochemistry

Background:

  • Male factor infertility (MFI) affects a significant portion of couples seeking fertility treatment.
  • Oxidative stress, indicated by elevated reactive oxygen species (ROS), is increasingly recognized as a contributing factor to male infertility.
  • Current diagnostic methods for MFI may not fully capture the role of oxidative stress.

Purpose of the Study:

  • To investigate abnormal patterns of ROS production in male factor infertility (MFI) patients.
  • To establish reference values for ROS in MFI patients.
  • To determine if ROS levels are an independent marker for MFI.

Main Methods:

  • Retrospective study design.
  • Analysis of 132 MFI patients and 34 healthy donors.
  • Routine semen analysis and measurement of ROS levels.

Main Results:

  • Healthy donors exhibited significantly higher sperm concentration, motility, and morphology than MFI patients (P<.0001).
  • Univariate and multivariate analyses revealed a significant independent association between MFI and elevated ROS levels (OR = 4.25).
  • ROS cutoff values between 1.2-1.4 demonstrated high sensitivity (0.70-0.78) and specificity (0.82) for MFI detection.

Conclusions:

  • Elevated ROS is an independent diagnostic marker for MFI, even with normal semen parameters.
  • Inclusion of ROS measurement in the evaluation of idiopathic infertility is recommended.
  • Antioxidant therapy may prove beneficial for MFI patients with high ROS levels.